Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

DHAMPUR BIO ORGANICS 2023-24 Annual Report Analysis
Thu, 13 Jun

DHAMPUR BIO ORGANICS has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

DHAMPUR BIO ORGANICS Income Statement Analysis

  • Operating income during the year fell 39.8% on a year-on-year (YoY) basis.
  • The company's operating profit decreased by 32.6% YoY during the fiscal. Operating profit margins witnessed a fall and down at 10.6% in FY24 as against 9.5% in FY23.
  • Depreciation charges increased by 22.0% and finance costs increased by 10.8% YoY, respectively.
  • Other income grew by 107.7% YoY.
  • Net profit for the year declined by 56.1% YoY.
  • Net profit margins during the year declined from 5.1% in FY23 to 3.8% in FY24.

DHAMPUR BIO ORGANICS Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 21,606 13,012 -39.8%
Other income Rs m 114 237 107.7%
Total Revenues Rs m 21,720 13,249 -39.0%
Gross profit Rs m 2,047 1,379 -32.6%
Depreciation Rs m 405 495 22.0%
Interest Rs m 408 453 10.8%
Profit before tax Rs m 1,348 669 -50.4%
Tax Rs m 237 181 -23.7%
Profit after tax Rs m 1,111 488 -56.1%
Gross profit margin % 9.5 10.6
Effective tax rate % 17.6 27.0
Net profit margin % 5.1 3.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Must See: These Segments are Witnessing Incredible Growth with Modi's Push

DHAMPUR BIO ORGANICS Balance Sheet Analysis

  • The company's current liabilities during FY24 stood at Rs 11 billion as compared to Rs 9 billion in FY23, thereby witnessing an increase of 20.6%.
  • Long-term debt stood at Rs 2 billion as compared to Rs 2 billion during FY23, a growth of 4.9%.
  • Current assets rose 8% and stood at Rs 12 billion, while fixed assets rose 14% and stood at Rs 11 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 23 billion as against Rs 21 billion during FY23, thereby witnessing a growth of 11%.

DHAMPUR BIO ORGANICS Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 9,887 10,207 3.2
 
Current Liabilities Rs m 8,814 10,634 20.6
Long-term Debt Rs m 1,687 1,770 4.9
Total Liabilities Rs m 20,999 23,252 10.7
 
Current assets Rs m 11,473 12,359 7.7
Fixed Assets Rs m 9,526 10,894 14.4
Total Assets Rs m 20,999 23,252 10.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



DHAMPUR BIO ORGANICS Cash Flow Statement Analysis

  • DHAMPUR BIO ORGANICS's cash flow from operating activities (CFO) during FY24 stood at Rs -1 billion on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs -1 billion on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs 2 billion, an improvement of 317% on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs -960 million from the Rs 811 million net cash flows seen during FY23.

DHAMPUR BIO ORGANICS Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m 3,681 -1,222 -
Cash Flow from Investing Activities Rs m -2,089 -1,435 -
Cash Flow from Financing Activities Rs m -781 1,696 -
Net Cash Flow Rs m 811 -960 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for DHAMPUR BIO ORGANICS

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 7.4, an decline from the EPS of Rs 16.7 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 154.1, stands at 22.0 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 1.0 times, while the price to sales ratio stands at 0.8 times.
  • The company's price to cash flow (P/CF) ratio stood at 10.3 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 325.4 196.0
TTM Earnings per share Rs 16.7 7.4
Diluted earnings per share Rs 16.7 7.4
Price to Cash Flow x 6.3 10.3
TTM P/E ratio x 8.6 22.0
Price / Book Value ratio x 1.2 1.0
Market Cap Rs m 11,425 10,159
Dividends per share (Unadj.) Rs 3.5 2.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for DHAMPUR BIO ORGANICS

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 1.2x during FY24, from 1.3x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 2.5x during FY24, from 4.3x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 4.8% during FY24, from 11.2% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 9.4% during FY24, from 15.2% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 4.0% during FY24, from 7.2% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 1.3 1.2
Debtors’ Days Days 3 2
Interest coverage x 4.3 2.5
Debt to equity ratio x 0.2 0.2
Return on assets % 7.2 4.0
Return on equity % 11.2 4.8
Return on capital employed % 15.2 9.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how DHAMPUR BIO ORGANICS has performed over the last 5 years, please visit here.

DHAMPUR BIO ORGANICS Share Price Performance

Over the last one year, DHAMPUR BIO ORGANICS share price has moved down from Rs 171.2 to Rs 154.1, registering a loss of Rs 17.1 or around 10.0%.

Overall, the S&P BSE SENSEX is up 22.5% over the year.

(To know more, check out historical annual results for DHAMPUR BIO ORGANICS and quarterly results for DHAMPUR BIO ORGANICS)

Annual Report FAQs

What is the current share price of DHAMPUR BIO ORGANICS?

DHAMPUR BIO ORGANICS currently trades at Rs 121.6 per share. You can check out the latest share price performance of DHAMPUR BIO ORGANICS here...

What was the revenue of DHAMPUR BIO ORGANICS in FY24? How does it compare to earlier years?

The revenues of DHAMPUR BIO ORGANICS stood at Rs 13,249 m in FY24, which was down -39.0% compared to Rs 21,720 m reported in FY23.

DHAMPUR BIO ORGANICS' revenue has grown from Rs 0 m in FY21 to Rs 13,249 m in FY24.

Over the past 4 years, the revenue of DHAMPUR BIO ORGANICS has grown at a CAGR of Infinity%.

What was the net profit of DHAMPUR BIO ORGANICS in FY24? How does it compare to earlier years?

The net profit of DHAMPUR BIO ORGANICS stood at Rs 488 m in FY24, which was down -56.1% compared to Rs 1,111 m reported in FY23.

This compares to a net profit of Rs 1,023 m in FY22 and a net loss of Rs 0 m in FY21.

Over the past 4 years, DHAMPUR BIO ORGANICS net profit has grown at a CAGR of NaN%.

What does the cash flow statement of DHAMPUR BIO ORGANICS reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of DHAMPUR BIO ORGANICS reveals:

  • Cash flow from operations decreased in FY24 and stood at Rs -1,222 m as compared to Rs 3,681 m in FY23.
  • Cash flow from investments increased in FY24 and stood at Rs -1,435 m as compared to Rs -2,089 m in FY23.
  • Cash flow from financial activity increased in FY24 and stood at Rs 1,696 m as compared to Rs -781 m in FY23.

Here's the cash flow statement of DHAMPUR BIO ORGANICS for the past 4 years.

(Rs m)FY21FY22FY23FY24
From Operations0-2,4653,681-1,222
From Investments0-1,378-2,089-1,435
From Financial Activity03,933-7811,696
Net Cashflow0230811-960

What does the Key Ratio analysis of DHAMPUR BIO ORGANICS reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of DHAMPUR BIO ORGANICS reveals:

  • Operating profit margins witnessed a fall and down at 10.6% in FY24 as against 9.5% in FY23.
  • Net profit margins declined from 5.1% in FY23 to 3.8% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.2 as compared to 0.2 in FY23.

Here's the ratio/financial analysis of DHAMPUR BIO ORGANICS for the past 4 years.

 FY21FY22FY23FY24
Operating Profit Margin (%)0.011.79.510.6
Net Profit Margin (%)0.06.55.13.8
Debt to Equity Ratio (x)0.10.10.20.2

Equitymaster requests your view! Post a comment on "DHAMPUR BIO ORGANICS 2023-24 Annual Report Analysis". Click here!